Gay, S., Raffa, S., Pietralata, A. D. d., Bauckneht, M., Vera, L., Miceli, A., . . . Ferone, D. (2022). 2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study. MDPI AG.
Chicago Style (17th ed.) CitationGay, Stefano, et al. 2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study. MDPI AG, 2022.
MLA (9th ed.) CitationGay, Stefano, et al. 2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.